Patents Assigned to Chimeric Therapies, Inc.
  • Patent number: 6039684
    Abstract: The present invention relates to the use of a non-lethal preparative regimen for the treatment of a patient with human immunodeficiency virus (HIV) disease. In a clinical trial, an HIV-positive patient was conditioned by non-lethal doses of irradiation and a chemotherapeutic drug prior to receiving donor bone marrow cells from a baboon. While long-term engraftment of donor cells was not observed, the non-lethal preparative conditioning regimen was able to reduce the viral burden and improved the clinical outcome. Such method is useful for treatment of patients with advanced acquired immunodeficiency syndrome (AIDS).
    Type: Grant
    Filed: December 11, 1997
    Date of Patent: March 21, 2000
    Assignees: Allegheny University of the Health Sciences, Chimeric Therapies, Inc.
    Inventors: Suzanne T. Ildstad, Olav B. Bergheim